Patient organisations – Improve diagnosis

Improve diagnosis of head and neck cancer

 

We are working with patient groups, both pan-European and country-specific to improve understanding of this disease and the importance of early diagnosis.

There are an estimated 400,000 to 600,000 new cases of all types of head and neck cancer globally each year and the mortality rate is between 223,000 and 300,000 deaths per year.¹ Head and neck cancer is the seventh most common type of cancer in Europe, with more than 150,000 new patients diagnosed in Europe in 2012.² 

We partner with the Make Sense campaign, which is led by the European Head and Neck Society (EHNS). The collaboration aims to raise awareness of sentinel lymph node biopsy, mapping and identification in head and neck cancer treatment. It also aims to highlight the importance of nuclear medicine as a critical part of the multi-disciplinary team.

¹ http://www.who.int/selection_medicines/committees/expert/20/applications/HeadNeck.pdf accessed on 14th March 2017
² http://makesensecampaign.eu/en/cancer-information/head-neck-cancer/ accessed on 14^th March 2017

 

 

Patient organisations we are collaborating with